Tag: cabozantinib

Cabozantinib is an oral tyrosine kinase inhibitor (TKI) used in the treatment of several advanced and metastatic cancers. It inhibits multiple pathways involved in tumor growth, angiogenesis, and metastasis, making it an important agent in targeted cancer therapy. Mechanism of Action Cabozantinib is a multi-kinase inhibitor that targets and inhibits several receptor tyrosine kinases implicated…